Medicare Coverage Issues Manual: Transmittal 143
Guidance that revises Section 60-14, Infusion Pumps to change the C-peptide requirement to be less than or equal to 110 percent of the lower limit of normal of the laboratory's measurement method. This change expands the value of the laboratory test to be considered in determining coverage of the insulin infusion pump for all diabetic patients. (Type II diabetics are no longer excluded.)
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 26, 2001
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.